Skip to main content
Insight

Fieldfisher Life Sciences Team Recognised in Legal 500

14/11/2017
The extensive Fieldfisher life sciences team has been ranked once again by the Legal 500 and many team members recognised for the specialist client advice.

We are delighted to be rated once again by Legal 500 in tier 2 and to have the following outstanding write-up for our extensive life sciences team:

Fieldfisher is singled out for its ‘strong market knowledge’ and its ability to ‘always be one step ahead in horizon-scanning and flagging up future developments that are likely to have on impact on clients’ business’. It is also praised for ‘providing clear strategic advice’ and ‘executing plans with excellence and ensuring excellent communication with the clients, barristers and lawyers in other jurisdictions’. The patent litigation practice was further strengthened when it hired three patent litigators from Rouse IP Limited in May 2016: the ‘very experienced’ Diana Sternfeld is singled out for her ‘exceptional client care’, Nicole Jadeja is praised for her ‘exceptional technical abilities’, and Rebecca Baines is ‘thorough and unflappable’. The practice is acting for GlaxoSmithKline in a multi-jurisdictional patent dispute with Pfizer relating to vaccines against Meningitis B, and [Dr Beatriz San Martin] is representing Sandoz and Hexal in a dispute with G.D. Searle and Janssen Sciences Ireland UC concerning the interpretation of SPC regulation. Alison Dennis has particular expertise in medical devices, advising a number of global companies on regulatory issues including pricing and promotions matters. Other key clients include Align Technology, which it advised on compliance and regulatory matters, as well as on its patent and trade mark enforcement strategy in the UK and Europe. Regulatory and public law partner Sarah Ellson is ‘exceptional in her approach’. Neil Matthews and Dominic Gurney-Champion are the key names to note in the corporate space. Data privacy expert Hazel Grant is also recommended.

Sign up to our email digest

Click to subscribe or manage your email preferences.

SUBSCRIBE